ProsTIC is the result of a vision from the Prostate Cancer Foundation. We aim to accelerate clinical trials and research in prostate cancer to facilitate better health outcomes for men. The additional support we receive from industry, collaborative research groups, advocacy, and philanthropic organisations, as well as government and our hospital, makes this a reality.
Philanthropy and advocacy organisations
Co-operative clinical trials groups
- The Australian and New Zealand Urogenital and Prostate (Anzuc) Cancer Trials Group
- Australasian Radiopharmaceutical Trials Network (ARTnet)
Industry
- Australia's Nuclear Science and Technology Organisation (ANSTO)
- MIM Software
- Isotopia Molecular Imaging
- Bayer
- Advanced Accelerator Applications